Renal Cancer Research Review, Issue 5

In this issue:

Axitinib to downstage cT2a renal tumours and allow partial nephrectomy
Stereotactic radiotherapy for renal tumours in the solitary kidney
Selecting patients with small renal masses for active surveillance
Metabolomics informs common patterns of molecular dysfunction across histologies of RCC
Abscopal effects in metastatic cancer patients during ICI therapy and irradiation
Needle track seeding in renal mass biopsies
Intermittent nivolumab in patients with mRCC
Impact of hospital nephrectomy volume on survival in RCC
Safety and efficacy of nivolumab in brain metastases from RCC
Limitations of existing prognostic models for predicting renal cancer recurrence

Please login below to download this issue (PDF)

Subscribe